Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immuncell-LC in Hepatocellular Carcinoma After Curative Resection
NCT00699816Phase 3Completed
- Sponsor
- GC Cell
- Start
- Jul 2008
- Primary completion
- Nov 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of immuncell-lc in hepatocellular carcinoma (HCC), sponsored by GC Cell. Started Jul 2008; status: completed.
02
Drugs
immuncell-lc
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00699816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699816.